{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:23:40Z","timestamp":1787775820763,"version":"build-2784847793"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>Coronavirus disease 2019 (COVID-19) which brings the epidemic situation to the public has spread rapidly and produce multiple variations. At present, Western medicine still lacks the specific medicine or vaccines for coronavirus. However, amount of evidence shows that traditional Chinese medicine (TCM) has advantages in releasing the symptoms of mild-to-moderate COVID patients. Those treatments are not only improving the course of the primary disease but also curb progress to severe pneumonia or acute respiratory distress syndrome. Therefore, taking TCM intervention or combined treatments appropriately to prevent worsening illness is of vital significance. This study mainly focuses on the data analysis on the effects of TCM in restoring the immune balance of COVID patients. By collecting clinical data from mild to moderate patients, we expected to figure out if TCM only plays the role of curbing inflammation or having a two-way influence in balancing the immune microenvironment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>Seven digital databases including PubMed, EMBASE, Cochrane Library, China National Knowledge Infrastructure, China Science and Technology Journal Database (VIP), Wanfang Database, and China Biology Medicine were searched from December 2019 to August 2022 nothingness of language restrictions. The studies retrieved from the database were selected and the data extracted to assess the methodological quality of the included randomized controlled trials (RCTs). Statistical analysis was completed. Pulmonary computed tomography, clinical cure rate, rate of conversion to severe cases, length of hospital stay, and scores of TCM syndrome were defined as the primary outcomes, the secondary outcomes were white blood cell count, lymphocyte (LYM) count, and C-reactive protein (CRP). This study was registered with PROSPERO (CRD42022341482).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Nine eligible RCTs including 1159 participants were included in this meta-analysis. Compared with Western medicine treatment alone, our meta-analyses found that traditional Chinese combined Western medicine treatment has a higher clinical cure rate, better absorption of lung inflammation, and significantly shorter hospital stay. In terms of inflammatory factors, TCM can significantly reduce the CRP content compared with Western medicine methods, but the leukocyte and LYM content was not significantly different between the two treatments. In some research, TCM even has a trend accelerating the inflammation process on some specific stages of the disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Chinese herbal medicine combined with conventional therapy is significantly effective and invulnerable in the treatment of mild-to-moderate COVID-19. In terms of control inflammation, TCM does not only block the disease onset by simply inhibiting inflammation but balancing the human environment through bidirectional regulation of inflammatory cells. However, considering of the lack of research into how TCM could activate the natural immune response, the discussion of the mechanism cannot be stretched, more high-quality RCTs are still needed in the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijp.ijp_234_23","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T07:00:09Z","timestamp":1772434809000},"page":"114-125","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Effects of Traditional Chinese Medicine on Restoroing the immune balance of mild-to-moderate Patients with new coronavirus"],"prefix":"10.4103","volume":"58","author":[{"given":"Sijie","family":"Chen","sequence":"first","affiliation":[{"name":"Ultrasound Medicine Department, Dazhou Women\u2019s and Children\u2019s Hospital, Dazhou, China"},{"name":"School of Clinical Medicine, Chengdu University of TCM, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Li","sequence":"additional","affiliation":[{"name":"Ultrasound Medicine Department, Dazhou Women\u2019s and Children\u2019s Hospital, Dazhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Hubei Enshi College, Enshi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingtian","family":"Liang","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Chengdu University of TCM, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Zhou","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, Chengdu University of TCM, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"R1-20260302","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jmii.2020.03.022","article-title":"Genotype and phenotype of COVID-19: Their roles in pathogenesis","volume":"54","author":"Mousavizadeh","year":"2021","journal-title":"J Microbiol Immunol Infect"},{"key":"R2-20260302","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.dsx.2021.04.007","article-title":"Long COVID: An overview","volume":"15","author":"Raveendran","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"R3-20260302","doi-asserted-by":"crossref","first-page":"107843","DOI":"10.1016\/j.pharmthera.2021.107843","article-title":"Traditional Chinese medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms","volume":"225","author":"Huang","year":"2021","journal-title":"Pharmacol Ther"},{"key":"R4-20260302","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1016\/j.apsb.2021.09.008","article-title":"Traditional Chinese medicine in COVID-19","volume":"11","author":"Lyu","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"R5-20260302","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.cjtee.2020.06.003","article-title":"Guideline for diagnosis and treatment of spine trauma in the epidemic of COVID-19","volume":"23","author":"Wang","year":"2020","journal-title":"Chin J Traumatol"},{"key":"R6-20260302","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/JCMA.0000000000000732","article-title":"A Houttuynia cordata-based Chinese herbal formula improved symptoms of allergic rhinitis during the COVID-19 pandemic","volume":"85","author":"Chang","year":"2022","journal-title":"J Chin Med Assoc"},{"key":"R7-20260302","doi-asserted-by":"crossref","first-page":"832321","DOI":"10.3389\/fnut.2022.832321","article-title":"Efficacy and safety of complementary therapy with Jing Si herbal tea in patients with mild-to-moderate COVID-19: A prospective cohort study","volume":"9","author":"Hsieh","year":"2022","journal-title":"Front Nutr"},{"key":"R8-20260302","doi-asserted-by":"crossref","first-page":"114220","DOI":"10.1016\/j.jep.2021.114220","article-title":"Positive effects of Lianhuaqingwen granules in COVID-19 patients: A retrospective study of 248 cases","volume":"278","author":"Shen","year":"2021","journal-title":"J Ethnopharmacol"},{"key":"R9-20260302","first-page":"23","article-title":"Clinical study on the treatment of novel coronavirus pneumonia with damp heat stagnation of the lung syndrome with the decoction for removing dampness and detoxification","volume":"42","author":"Song","year":"2021","journal-title":"Yunnan J Tradit Chin Med Mater Med"},{"key":"R10-20260302","first-page":"656","article-title":"Clinical effects of Qingfei Paidu decoction combined with conventional treatment on patients with coronavirus disease 2019","volume":"43","author":"Wang","year":"2021","journal-title":"Chin Tradit Pat Med"},{"key":"R11-20260302","article-title":"Clinical Observation on the Therapeutic Effect of Yiqi Fanggan Recipe in the Treatment of Common cold (Syndrome of Qi Deficiency and Evil Invading Dampness) under the Prevention and Control of COVID-19 and its Influence on the Level of Inflammatory Factors","author":"Zhang","year":"2021","journal-title":"Master Thesis, Chengdu: Chengdu University of Traditional Chinese Medicine"},{"key":"R12-20260302","first-page":"846","article-title":"Clinical study on Xuanfei Dayu decoction in treating recovery stage of novel coronavirus pneumonia","volume":"41","author":"Zhao","year":"2020","journal-title":"Shaanxi J Tradit Chin Med"},{"key":"R13-20260302","first-page":"1450","article-title":"Clinical analysis of 75 cases of novel coronavirus pneumonia treated by integrated traditional Chinese and Western medicine","volume":"31","author":"Su","year":"2020","journal-title":"Lishizhen Med Mater Med Res"},{"key":"R14-20260302","first-page":"641","article-title":"Observation on clinical therapeutic effect of Yiguan no. 1 prescription in treatment of patients with suspected coronavirus disease 2019","volume":"27","author":"Wang","year":"2020","journal-title":"Chin J Integr Tradit West Med Intensive Crit Care"},{"key":"R15-20260302","first-page":"1","article-title":"Guidelines for imaging assisted diagnosis of COVID-19","volume":"36","year":"2020","journal-title":"Chin J Med Imaging Technol"},{"key":"R17-20260302","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"R19-20260302","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3389\/fimmu.2020.01446","article-title":"The COVID-19 cytokine storm;what we know so far","volume":"11","author":"Ragab","year":"2020","journal-title":"Front Immunol"},{"key":"R20-20260302","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"R21-20260302","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med"},{"key":"R22-20260302","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cytogfr.2020.04.002","article-title":"Cytokine storm intervention in the early stages of COVID-19 pneumonia","volume":"53","author":"Sun","year":"2020","journal-title":"Cytokine Growth Factor Rev"},{"key":"R23-20260302","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cytogfr.2020.06.001","article-title":"SARS-CoV-2 infection: The role of cytokines in COVID-19 disease","volume":"54","author":"Costela-Ruiz","year":"2020","journal-title":"Cytokine Growth Factor Rev"},{"key":"R24-20260302","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/infdis\/jiaa363","article-title":"Serum cytokine and chemokine profile in relation to the severity of coronavirus disease 2019 in China","volume":"222","author":"Chi","year":"2020","journal-title":"J Infect Dis"},{"key":"R25-20260302","doi-asserted-by":"crossref","first-page":"153390","DOI":"10.1016\/j.phymed.2020.153390","article-title":"Shufeng Jiedu, a promising herbal therapy for moderate COVID-19: Antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study","volume":"85","author":"Xia","year":"2021","journal-title":"Phytomedicine"},{"key":"R26-20260302","first-page":"35","article-title":"Experimental study of gardenoside against viral pneumonia caused by influenza virus based on TLR3\/TRIF pathway","volume":"36","author":"Wang","year":"2020","journal-title":"Chin J Virol"},{"key":"R27-20260302","doi-asserted-by":"crossref","first-page":"104820","DOI":"10.1016\/j.phrs.2020.104820","article-title":"Chemical composition and pharmacological mechanism of Qingfei Paidu decoction and Ma Xing Shi Gan decoction against coronavirus disease 2019 (COVID-19): In silico and experimental study","volume":"157","author":"Yang","year":"2020","journal-title":"Pharmacol Res"},{"key":"R28-20260302","first-page":"901","article-title":"Study on the substantial basis and mechanism of action of Qingfei Detu decoction in treating COVID-19 based on network pharmacology","volume":"32","author":"Xu","year":"2020","journal-title":"Nat Prod Res Dev"},{"key":"R29-20260302","first-page":"5507003","article-title":"Network pharmacology-based identification of potential targets of Lonicerae japonicae Flos acting on anti-inflammatory effects","author":"Guo","year":"2021","journal-title":"Biomed Res Int 2021"},{"key":"R30-20260302","doi-asserted-by":"crossref","first-page":"eabg5021","DOI":"10.1126\/sciimmunol.abg5021","article-title":"Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients","volume":"6","author":"Notarbartolo","year":"2021","journal-title":"Sci Immunol"},{"key":"R31-20260302","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/ptr.6873","article-title":"Natural products for COVID-19 prevention and treatment regarding to previous coronavirus infections and novel studies","volume":"35","author":"Boozari","year":"2021","journal-title":"Phytother Res"},{"key":"R32-20260302","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/s41401-020-0483-6","article-title":"Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients","volume":"41","author":"Su","year":"2020","journal-title":"Acta Pharmacol Sin"},{"key":"R33-20260302","first-page":"139","article-title":"Potential treatment of COVID-19 with traditional Chinese medicine: What herbs can help win the battle with SARS-CoV-2?","volume":"19","author":"Li","year":"2022","journal-title":"Engineering (Beijing)"},{"key":"R34-20260302","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1007\/s00216-021-03233-7","article-title":"Screening and evaluation of anti-SARS-CoV-2 components from Ephedra sinica by ACE2\/CMC-HPLC-IT-TOF-MS approach","volume":"413","author":"Lv","year":"2021","journal-title":"Anal Bioanal Chem"},{"key":"R35-20260302","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00430-010-0155-0","article-title":"Glycyrrhizin inhibits highly pathogenic H5N1 influenza A virus-induced pro-inflammatory cytokine and chemokine expression in human macrophages","volume":"199","author":"Michaelis","year":"2010","journal-title":"Med Microbiol Immunol"},{"key":"R36-20260302","doi-asserted-by":"crossref","first-page":"106560","DOI":"10.1016\/j.intimp.2020.106560","article-title":"Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids","volume":"84","author":"Saghazadeh","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"R37-20260302","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s12272-020-01228-z","article-title":"Transcriptional suppression of androgen receptor by 18?-glycyrrhetinic acid in LNCaP human prostate cancer cells","volume":"43","author":"Sun","year":"2020","journal-title":"Arch Pharm Res"},{"key":"R38-20260302","doi-asserted-by":"crossref","first-page":"114063","DOI":"10.1016\/j.jep.2021.114063","article-title":"Antiviral effect of fufang yinhua jiedu (FFYH) granules against influenza A virus through regulating the inflammatory responses by TLR7\/MyD88 signaling pathway","volume":"275","author":"Zhang","year":"2021","journal-title":"J Ethnopharmacol"},{"key":"R39-20260302","first-page":"322","article-title":"Screening for genes associated with natural killer cell mediated cytotoxicity in pneumonia mice infected with influenza virus and regulation of two herbal anti-virus formulas","volume":"25","author":"Lu","year":"2013","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"R40-20260302","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3389\/fphar.2019.00898","article-title":"Astragaloside III enhances anti-tumor response of NK cells by elevating NKG2D and IFN-?","volume":"10","author":"Chen","year":"2019","journal-title":"Front Pharmacol"},{"key":"R41-20260302","first-page":"5591","article-title":"Matrine regulates immune functions to inhibit the proliferation of leukemic cells","volume":"8","author":"Zhang","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"R42-20260302","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1111\/ene.14913","article-title":"Encephalitis as a neurological complication of COVID-19: A systematic review and meta-analysis of incidence, outcomes, and predictors","volume":"28","author":"Siow","year":"2021","journal-title":"Eur J Neurol"},{"key":"R43-20260302","doi-asserted-by":"crossref","first-page":"104761","DOI":"10.1016\/j.phrs.2020.104761","article-title":"Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)","volume":"156","author":"Li","year":"2020","journal-title":"Pharmacol Res"},{"key":"R44-20260302","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/AOG.0000000000004695","article-title":"Association between menstrual cycle length and coronavirus disease 2019 (COVID-19) vaccination: A U. S. Cohort","volume":"139","author":"Edelman","year":"2022","journal-title":"Obstet Gynecol"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.ijp_234_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:43:13Z","timestamp":1787773393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.ijp_234_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/ijp.ijp_234_23","relation":{},"ISSN":["0253-7613","1998-3751"],"issn-type":[{"value":"0253-7613","type":"print"},{"value":"1998-3751","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"2023-04-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}